Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Net Receivables

$790.00K

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Net Receivables

Latest reported$790.00Kperiod endingJun 30, 2026

Latest reported$790.00Kperiod endingJun 30, 2026

LCTX Quarterly Net Receivables ($0.00 → $790.00K)

Quarterly net receivables

High-resolution chart · PNG

LCTX net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Net Receivables — Quarterly (USD)
Period ending	Net Receivables (USD)
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	0
Sep 30, 2000	0
Jun 30, 2000	0
Mar 31, 2000	0
Dec 31, 1999	0
Sep 30, 1999	0
Jun 30, 1999	900,000
Mar 31, 1999	300,000
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.